Related Experiment Video
Updated: Jun 30, 2025
Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
Blunted blades: new CRISPR-derived technologies to dissect microbial multi-drug resistance and biofilm formation
Christopher Gager1, Ana L Flores-Mireles1,2
1Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Abstract:
The spread of multi-drug-resistant (MDR) pathogens has rapidly outpaced the development of effective treatments. Diverse resistance mechanisms further limit the effectiveness of our best treatments, including multi-drug regimens and last line-of-defense antimicrobials. Biofilm formation is a powerful component of microbial pathogenesis, providing a scaffold for efficient colonization and shielding against anti-microbials, which further complicates drug resistance studies. Early genetic knockout tools didn't allow the study of essential genes, but clustered regularly interspaced palindromic repeat inference (CRISPRi) technologies have overcome this challenge via genetic silencing. These tools rapidly evolved to meet new demands and exploit native CRISPR systems. Modern tools range from the creation of massive CRISPRi libraries to tunable modulation of gene expression with CRISPR activation (CRISPRa). This review discusses the rapid expansion of CRISPRi/a-based technologies, their use in investigating MDR and biofilm formation, and how this drives further development of a potent tool to comprehensively examine multi-drug resistance.
Insights
Clustered regularly interspaced palindromic repeat interference (CRISPRi) and activation (CRISPRa) technologies enable genetic silencing and activation, revolutionizing the study of multi-drug resistance (MDR) and biofilm formation in pathogens.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- Multi-drug-resistant (MDR) pathogens pose a significant global health threat, with treatment options dwindling.
- Biofilm formation by microbes enhances pathogenicity and confers resistance to antimicrobials, complicating therapeutic strategies.
- Traditional genetic tools were limited in studying essential genes, hindering comprehensive understanding of resistance mechanisms.
Purpose of the Study:
- To review the advancements and applications of CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) technologies.
- To highlight the utility of CRISPRi/a in investigating multi-drug resistance (MDR) and biofilm formation.
- To discuss how these technologies drive the development of novel tools for studying antimicrobial resistance.
Main Methods:
- Review of CRISPRi/a-based technologies and their evolution.
- Analysis of CRISPRi/a applications in studying microbial pathogenesis, specifically MDR and biofilms.
- Discussion of the impact of CRISPRi/a on the development of new research tools.
Main Results:
- CRISPRi/a technologies offer powerful genetic manipulation capabilities, including gene silencing and tunable expression modulation.
- These tools have overcome limitations of previous genetic methods, enabling the study of essential genes.
- CRISPRi/a are instrumental in dissecting the complex mechanisms underlying MDR and biofilm development.
Conclusions:
- CRISPRi/a technologies represent a significant advancement in microbial genetics and drug resistance research.
- The application of CRISPRi/a is crucial for a comprehensive understanding of MDR and biofilm formation.
- Continued development of CRISPRi/a platforms will accelerate the discovery of new therapeutic strategies against resistant pathogens.
Related Concept Videos
02:53CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
01:59CRISPR
00:57Antibiotic Selection